NL8204108A - In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen. - Google Patents

In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen. Download PDF

Info

Publication number
NL8204108A
NL8204108A NL8204108A NL8204108A NL8204108A NL 8204108 A NL8204108 A NL 8204108A NL 8204108 A NL8204108 A NL 8204108A NL 8204108 A NL8204108 A NL 8204108A NL 8204108 A NL8204108 A NL 8204108A
Authority
NL
Netherlands
Prior art keywords
group
monoclonal antibody
tumor
chelating agent
antibody
Prior art date
Application number
NL8204108A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of NL8204108A publication Critical patent/NL8204108A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1066—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL8204108A 1981-10-27 1982-10-25 In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen. NL8204108A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31528681A 1981-10-27 1981-10-27
US31528681 1981-10-27

Publications (1)

Publication Number Publication Date
NL8204108A true NL8204108A (nl) 1983-05-16

Family

ID=23223718

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8204108A NL8204108A (nl) 1981-10-27 1982-10-25 In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen.

Country Status (18)

Country Link
JP (1) JPS58135820A (no)
AT (1) AT392004B (no)
BE (1) BE894829A (no)
CA (1) CA1202892A (no)
CH (1) CH653040A5 (no)
DE (1) DE3239410A1 (no)
DK (1) DK164682C (no)
ES (2) ES516797A0 (no)
FI (1) FI82379C (no)
FR (1) FR2515046B1 (no)
GB (1) GB2109407B (no)
IL (1) IL67068A0 (no)
IT (1) IT1153857B (no)
LU (1) LU84441A1 (no)
NL (1) NL8204108A (no)
NO (1) NO169947C (no)
SE (1) SE8206073L (no)
ZA (1) ZA827806B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
CA1225930A (en) * 1982-06-07 1987-08-25 Otto A. Gansow Metal chelate conjugated monoclonal antibodies
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
SE8401945L (sv) * 1983-04-08 1984-11-13 Kureha Chemical Ind Co Ltd Antikropp mot cancer i urinblasan hos menniska
GB2139645A (en) * 1983-04-08 1984-11-14 Kureha Chemical Ind Co Ltd Antibody to human prostrate cancer
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
JP2507982B2 (ja) * 1984-04-10 1996-06-19 武田薬品工業株式会社 ヒト癌胎児性抗原反応性モノクロ―ナル抗体の製造法
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US5082930A (en) * 1986-05-29 1992-01-21 Mallinckrodt Medical, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4925804A (en) * 1986-06-17 1990-05-15 Baxter International Inc. Interligand metal transfer assay
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
CA1340014C (en) * 1986-10-27 1998-08-25 Bryan Michael Longenecker Carcinoma-marking monoclonal antibodies elicited with synthetic asialo-gmi antigen
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
US5227474A (en) * 1987-02-13 1993-07-13 Abbott Laboratories Bifunctional chelating agents
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US4838274A (en) * 1987-09-18 1989-06-13 Air Products And Chemicals, Inc. Perfluoro-crown ethers in fluorine magnetic resonance imaging
US5217704A (en) * 1987-11-06 1993-06-08 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5688488A (en) * 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
ES2146217T3 (es) * 1992-07-31 2000-08-01 Australian Nuclear Science Tec Agentes quelantes de los acidos aminocarboxilicos con hidroxiarilo.
US7521531B2 (en) 1996-08-28 2009-04-21 Immunomedics, Inc. Methods for the purification of stable radioiodine conjugates
US6663866B1 (en) 1996-08-28 2003-12-16 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis
US6558669B1 (en) 1996-08-28 2003-05-06 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
DE3173342D1 (en) * 1980-03-03 1986-02-13 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments

Also Published As

Publication number Publication date
ES529310A0 (es) 1985-05-16
AT392004B (de) 1991-01-10
NO823530L (no) 1983-04-28
NO169947B (no) 1992-05-18
CA1202892A (en) 1986-04-08
IL67068A0 (en) 1983-02-23
CH653040A5 (de) 1985-12-13
SE8206073D0 (sv) 1982-10-26
ZA827806B (en) 1983-08-31
DK164682B (da) 1992-08-03
FR2515046B1 (fr) 1985-11-29
ES8505482A1 (es) 1985-05-16
ATA391682A (de) 1990-07-15
DE3239410C2 (no) 1991-12-19
JPS58135820A (ja) 1983-08-12
FI823633A0 (fi) 1982-10-25
IT1153857B (it) 1987-01-21
BE894829A (fr) 1983-02-14
ES8404857A1 (es) 1984-05-16
FR2515046A1 (fr) 1983-04-29
GB2109407B (en) 1985-12-18
DK474182A (da) 1983-04-28
DK164682C (da) 1992-12-21
IT8223932A0 (it) 1982-10-26
NO169947C (no) 1992-08-26
FI823633L (fi) 1983-04-28
DE3239410A1 (de) 1983-05-19
LU84441A1 (fr) 1983-06-13
ES516797A0 (es) 1984-05-16
JPH0564130B2 (no) 1993-09-14
FI82379C (fi) 1991-03-11
SE8206073L (sv) 1983-04-28
FI82379B (fi) 1990-11-30
GB2109407A (en) 1983-06-02

Similar Documents

Publication Publication Date Title
NL8204108A (nl) In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen.
Primus et al. Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen
Anderson et al. Copper-64-labeled antibodies for PET imaging
Deshpande et al. Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice
EP0173629A1 (en) Antibody-metal ion complexes
WO1991014459A1 (en) A bifunctional dtpa-type ligand
Anderson-Berg et al. Specific radioimmunotherapy using 90Y-labeled monoclonal antibody in erythroleukemic mice
WO1987000756A1 (en) Agents for use in tumour diagnosis, imaging, localization or treatment
JP2012131808A (ja) 減少した正味の正電荷を有する抗体
Stein et al. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung
Buchsbaum et al. Comparison of the distribution and binding of monoclonal antibodies labeled with 131-iodine or 111-indium
ZIMMER et al. Radioimmunoimaging of human small cell lung carcinoma with I-131 tumor specific monoclonal antibody
US5380513A (en) Methods for reducing non-target retention of immunoconjugates and metabolites thereof
WO1997025069A9 (en) Antibodies with reduced net positive charge
Hwang et al. Dynamic interaction of 111indium-labeled monoclonal antibodies with surface antigens of solid tumors visualized in vivo by external scintigraphy
EP0614377A1 (en) Method for diagnosing and treating cancer
Hansen et al. Labeling of anti-tumor antibodies and antibody fragments with Tc-99m
EP0090025A1 (en) Specific mammary gland labelling
Endo et al. Tumor imaging by monoclonal antibodies labeled with radioactive metal ions
Endo et al. Monoclonal Antibody and Nuclear Medicine; Radioimmunoimaging of Tumor with Radiolabeled Monoclonal Antibody
Udayachander et al. Tumor imaging of Dalton's lymphoma using antibody-desferal-Ga-67 complex
Larson et al. Radioimmunoscintigraphy by means of melanoma antibody
Halpern et al. Preclinical and clinical studies with in-111 anti-CEA antibodies and fragments
Philpott et al. Copper-64-Labeled Antibodies for PET Imaging
NO177454B (no) Diagnostisiseringsmiddel

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed